Applied UV Granted Patents for Device Sterilizing ATM Surfaces

Applied UV, a pathogen elimination technology company that applies the power of narrow-range ultraviolet light for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, announces that its wholly owned subsidiary SteriLumen has been notified that the US Patent and Trademark Office (USPTO) has granted the patent pertaining to a system to neutralize pathogens on ATM surfaces.
 
On a daily basis, consumers globally interact with numerous surfaces that need to be touched during normal uses, including ATMs with keyboards and interactive touch screens. As an example, as of 2018, there were approximately 470,000 ATMs in the U.S. alone. These surfaces are touched daily by an inordinate number of people that can harbor and transfer pathogens highly associated with illnesses and diseases. E.coli, salmonella and Staphylococcus aureus can be found on these commonly used surfaces and can easily spread to those in the general public if untreated; these bacteria and viruses can be transferred easily to cause serious illness.

Banks are reducing the threat of litigation risk by incorporating the use of the best science available to protect consumers from contracting serious illnesses due to deadly surface pathogens found on ATMs.